Close Menu
Home » 23andMe Gets FDA Clearance to Market Bloom Syndrome Carrier Test Directly to Consumers

23andMe Gets FDA Clearance to Market Bloom Syndrome Carrier Test Directly to Consumers

Feb 19, 2015
|
staff reporter

NEW YORK (GenomeWeb) – 23andMe has received clearance from the US Food and Drug Administration to market its first health-related test, for Bloom syndrome, directly to consumers.

The test determines whether a healthy person carriers a genetic variant that could be passed on to a child. Bloom syndrome is an autosomal recessive disorder that results in short stature and a predisposition to cancer. The child must inherit two abnormal alleles in order to have symptoms of the syndrome.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Whittling Down the Database

The New York City Police Department will be removing DNA profiles from a local database if they are from people who were never convicted of a crime, the New York Times reports.

Accusations and Certifications

Science reports that accusations of sexual assault against a microbiome researcher has also led to questions about his academic certifications.

DNA That Floats Behind

Wired reports that researchers are analyzing the DNA fish leave behind in water to study their populations.

Science Papers Include Thymus Cellular Map, Ancient Archaic Hominin Admixture

In Science this week: comprehensive cellular map of the human thymus, evidence of admixture between the ancestors of Neanderthals and Denisovan and a 'superarchaic' population.

Feb
25
Featured Webinar

Long-Read Sequencing of Human Transcription Provides Insights into Metastatic Cancer

Sponsored by
Loop Genomics

This webinar will discuss a study that used long-read transcriptome sequencing to explore the distribution of isoforms in colon cancer samples and their metastasis counterparts. 

Feb
26
Featured Webinar

Transformation of the Lab to Fight Genetic Illnesses in the Amish and Mennonite Populations

Sponsored by
Autogen

This webinar will explain how the Clinic for Special Children in Strasburg, Pennsylvania, has transformed its DNA workflows to improve the diagnosis and treatment of genetic illnesses that are prevalent in the pediatric population of its community.

Feb
27
Featured Webinar

Digital PCR Method Development for Accurate Quantification of Copy Number Variations

Sponsored by
Stilla

Since the publication of the “The Digital MIQE Guidelines: Minimum Information for Publication of Quantitative Digital PCR Experiments” (dMIQE) in 2013, there has been a large expansion of the applications of dPCR such as single nucleotide variations (SNVs) and copy number variations (CNVs) measurements associated with disease diagnostics.

Mar
18
Featured Webinar

Comparison of Genome-Wide versus Targeted cfDNA Testing for First-Line Prenatal Screening: Real-World Data

Sponsored by
Roche

This webinar will discuss data from a recent real-world comparison study evaluating performance of two cell-free DNA methodologies as first-line prenatal screens.

What's Popular?

In Molecular Diagnostics

  1. FDA Releases List of Evidence-Based PGx Variants

  2. FIND, WHO Collaborate on Novel Coronavirus MDx Evaluation

  3. Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing

  4. Invitae Q4 2019 Revenues Increase 47 Percent

  5. Novacyt Gets CE Mark for Coronavirus Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.